HEADER ANTI-ONCOGENE 13-FEB-98 2A5E TITLE SOLUTION NMR STRUCTURE OF TUMOR SUPPRESSOR P16INK4A, RESTRAINED TITLE 2 MINIMIZED MEAN STRUCTURE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TUMOR SUPPRESSOR P16INK4A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3) KEYWDS ANTI-ONCOGENE, TUMOR-SUPPRESSOR-P16INK4A EXPDTA SOLUTION NMR AUTHOR I.-J.L.BYEON,J.LI,K.ERICSON,T.L.SELBY,A.TEVELEV,H.-J.KIM,P.O'MAILLE, AUTHOR 2 M.-D.TSAI REVDAT 4 09-MAR-22 2A5E 1 REMARK REVDAT 3 24-FEB-09 2A5E 1 VERSN REVDAT 2 01-APR-03 2A5E 1 JRNL REVDAT 1 13-AUG-99 2A5E 0 JRNL AUTH I.J.BYEON,J.LI,K.ERICSON,T.L.SELBY,A.TEVELEV,H.J.KIM, JRNL AUTH 2 P.O'MAILLE,M.D.TSAI JRNL TITL TUMOR SUPPRESSOR P16INK4A: DETERMINATION OF SOLUTION JRNL TITL 2 STRUCTURE AND ANALYSES OF ITS INTERACTION WITH JRNL TITL 3 CYCLIN-DEPENDENT KINASE 4. JRNL REF MOL.CELL V. 1 421 1998 JRNL REFN ISSN 1097-2765 JRNL PMID 9660926 JRNL DOI 10.1016/S1097-2765(00)80042-8 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER (X-PLOR), BRUNGER (X-PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2A5E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000177716. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 293 REMARK 210 PH : 7.5 REMARK 210 IONIC STRENGTH : CA. 0 REMARK 210 PRESSURE : NO REMARK 210 SAMPLE CONTENTS : H2O AND D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NMR EXPERIMENTS FOR THE REMARK 210 ASSIGNMENTS AND STRUCTURE REMARK 210 CALCULATIONS : HNCACB; CBCA(CO) REMARK 210 HN; HN(CO)CA; HCCH-TOCSY; HNHA; REMARK 210 3D 15N-EDITED NOESY AND TOCSY; REMARK 210 2D NOESY AND TOCSY; 3D 13C- REMARK 210 EDITED NOESY; 3D 15N/13C REMARK 210 SIMULTANEOUSLY EDITED NOESY; 4D REMARK 210 15N/13C-EDITED NOESY; 4D 13C/13C- REMARK 210 EDITED NOESY. REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : DMX600; DRX800 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 90 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 1 REMARK 210 CONFORMERS, SELECTION CRITERIA : CLOSEST TO MEAN STRUCTURE WHICH REMARK 210 SHOWS GOOD AGREEMENT WITH THE REMARK 210 CONSTRAINTS. NONE OF THE REMARK 210 CONSTRAINTS SHOW NOE VIOLATION REMARK 210 BIGGER THAN 0.5 A AND DIHEDRAL REMARK 210 ANGLE VIOLATION BIGGER THAN 5 REMARK 210 DEGREE. REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: THE SOLUTION STRUCTURE OF THE TUMOR SUPPRESSOR P16INK4A REMARK 210 HAS BEEN DETERMINED BY MULTI-DIMENSIONAL HERERONUCLEAR NMR. THE REMARK 210 STRUCTURES WERE CALCULATED USING THE SIMULATED ANNEALING REMARK 210 PROTOCOL OF NILGES ET AL. (1988) FEBS LETT. 229, 129-136 USING REMARK 210 THE PROGRAM X-PLOR 3.1 (BRUNGER). THE CALCULATION IS BASED ON REMARK 210 1437 EXPERIMENTAL NMR RESTRAINTS (1370 DISTANCE AND 67 TORSION REMARK 210 ANGLE RESTRAINTS). REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 11 H ALA A 13 1.19 REMARK 500 O ASP A 108 H TRP A 110 1.48 REMARK 500 O ASP A 14 H THR A 18 1.57 REMARK 500 O PRO A 11 N ALA A 13 1.99 REMARK 500 OD2 ASP A 146 O PRO A 151 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 2 104.51 -47.33 REMARK 500 ALA A 4 44.05 71.41 REMARK 500 ALA A 5 -54.90 169.89 REMARK 500 SER A 7 -129.65 -72.37 REMARK 500 SER A 8 -90.72 61.61 REMARK 500 MET A 9 29.57 45.37 REMARK 500 SER A 12 11.48 -34.64 REMARK 500 ASN A 39 70.78 -117.86 REMARK 500 MET A 53 -17.71 69.07 REMARK 500 ALA A 68 -161.21 -63.62 REMARK 500 ASN A 71 -63.15 -104.81 REMARK 500 CYS A 72 152.17 -49.49 REMARK 500 LEU A 78 28.64 49.32 REMARK 500 ALA A 102 115.46 -163.86 REMARK 500 ASP A 105 50.71 -111.97 REMARK 500 VAL A 106 -169.12 -108.39 REMARK 500 ALA A 109 -60.84 62.07 REMARK 500 HIS A 123 56.66 -96.06 REMARK 500 ARG A 138 -103.17 -135.80 REMARK 500 SER A 140 -140.37 41.93 REMARK 500 HIS A 142 153.32 58.46 REMARK 500 ALA A 143 -121.18 124.87 REMARK 500 ILE A 145 -13.07 123.52 REMARK 500 ASP A 146 -35.82 78.92 REMARK 500 ALA A 148 76.73 -8.85 REMARK 500 GLU A 149 76.36 1.97 REMARK 500 SER A 152 -158.80 171.71 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: PLANAR GROUPS REMARK 500 REMARK 500 PLANAR GROUPS IN THE FOLLOWING RESIDUES HAVE A TOTAL REMARK 500 RMS DISTANCE OF ALL ATOMS FROM THE BEST-FIT PLANE REMARK 500 BY MORE THAN AN EXPECTED VALUE OF 6*RMSD, WITH AN REMARK 500 RMSD 0.02 ANGSTROMS, OR AT LEAST ONE ATOM HAS REMARK 500 AN RMSD GREATER THAN THIS VALUE REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI RMS TYPE REMARK 500 ARG A 22 0.14 SIDE CHAIN REMARK 500 ARG A 24 0.32 SIDE CHAIN REMARK 500 ARG A 29 0.22 SIDE CHAIN REMARK 500 ARG A 46 0.27 SIDE CHAIN REMARK 500 ARG A 47 0.17 SIDE CHAIN REMARK 500 ARG A 58 0.24 SIDE CHAIN REMARK 500 ARG A 80 0.32 SIDE CHAIN REMARK 500 ARG A 87 0.18 SIDE CHAIN REMARK 500 ARG A 99 0.29 SIDE CHAIN REMARK 500 ARG A 103 0.30 SIDE CHAIN REMARK 500 ARG A 107 0.20 SIDE CHAIN REMARK 500 ARG A 112 0.30 SIDE CHAIN REMARK 500 ARG A 124 0.31 SIDE CHAIN REMARK 500 ARG A 131 0.24 SIDE CHAIN REMARK 500 ARG A 138 0.31 SIDE CHAIN REMARK 500 ARG A 144 0.24 SIDE CHAIN REMARK 500 REMARK 500 REMARK: NULL DBREF 2A5E A 1 156 UNP P42771 CDN2A_HUMAN 1 156 SEQRES 1 A 156 MET GLU PRO ALA ALA GLY SER SER MET GLU PRO SER ALA SEQRES 2 A 156 ASP TRP LEU ALA THR ALA ALA ALA ARG GLY ARG VAL GLU SEQRES 3 A 156 GLU VAL ARG ALA LEU LEU GLU ALA GLY ALA LEU PRO ASN SEQRES 4 A 156 ALA PRO ASN SER TYR GLY ARG ARG PRO ILE GLN VAL MET SEQRES 5 A 156 MET MET GLY SER ALA ARG VAL ALA GLU LEU LEU LEU LEU SEQRES 6 A 156 HIS GLY ALA GLU PRO ASN CYS ALA ASP PRO ALA THR LEU SEQRES 7 A 156 THR ARG PRO VAL HIS ASP ALA ALA ARG GLU GLY PHE LEU SEQRES 8 A 156 ASP THR LEU VAL VAL LEU HIS ARG ALA GLY ALA ARG LEU SEQRES 9 A 156 ASP VAL ARG ASP ALA TRP GLY ARG LEU PRO VAL ASP LEU SEQRES 10 A 156 ALA GLU GLU LEU GLY HIS ARG ASP VAL ALA ARG TYR LEU SEQRES 11 A 156 ARG ALA ALA ALA GLY GLY THR ARG GLY SER ASN HIS ALA SEQRES 12 A 156 ARG ILE ASP ALA ALA GLU GLY PRO SER ASP ILE PRO ASP HELIX 1 IA ASP A 14 ARG A 22 1 9 HELIX 2 IB VAL A 25 GLY A 35 1 11 HELIX 3 IIA ARG A 47 VAL A 51 1 5 HELIX 4 IIB ALA A 57 HIS A 66 1 10 HELIX 5 3A PRO A 81 GLU A 88 1 8 HELIX 6 3B LEU A 91 ALA A 100 1 10 HELIX 7 IVA PRO A 114 LEU A 121 1 8 HELIX 8 IVB ARG A 124 ALA A 134 1 11 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000